Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiopulmonary Resuscitation III: AED Use

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An Insight Into a Potential Antithrombin-Independent Mechanism of Inadequate Heparin Response in Neonates and Infants Undergoing Pediatric Cardiac Surgery: An Exploratory Study.

Journal of cardiothoracic and vascular anesthesia·2026

Same author

Green synthesis and characterization of silver nanoparticles from the aerial parts of Leucas lanata with enhanced antioxidant and antimicrobial activities.

Discover nano·2026

Same author

Postoperative pulmonary complications after neuromuscular blockade: what does the recent evidence demonstrate?

Journal of thoracic disease·2026

Same author

Risk Factor Analysis of Inadequate Heparin Response in Pediatric Cardiac Surgery.

Journal of cardiothoracic and vascular anesthesia·2026

Same author

Intraoperative Hypotension in Children Undergoing Noncardiac Surgery: An Exploratory Single-Center Analysis of Incidence, Associated Risk Factors, and Outcomes.

Anesthesia and analgesia·2026

Same author

Synthesis and characterization of zinc oxide nanoparticles by the aerial part of <i>Artemisia roxburghiana</i> extract and assessment of their biological activities.

Zeitschrift fur Naturforschung. C, Journal of biosciences·2026

Search research articles

Related Experiment Video

Updated: May 19, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Ventricular-assist device therapy in children.

Koichi Yuki¹, Ruchika Sharma, James DiNardo

¹Division of Cardiac Anesthesia, Department of Anesthesiology, Perioperative and Pain Medicine, Children's Hospital Boston, Boston, MA 02115, USA. koichi.yuki@childrens.harvard.edu

Best Practice & Research. Clinical Anaesthesiology

|August 23, 2012

Summary

This summary is machine-generated.

Mechanical circulatory support devices, such as ventricular assist devices (VADs), are crucial for children with heart failure. This review covers VADs for pediatric patients and anesthesia management for VAD implantation and non-cardiac surgeries.

More Related Videos

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Related Experiment Videos

Last Updated: May 19, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Area of Science:

Pediatric cardiology
Cardiovascular surgery
Anesthesiology

Background:

Mechanical circulatory support (MCS) is vital for managing pediatric circulatory failure.
Ventricular assist device (VAD) technology is rapidly advancing for pediatric applications.
Anesthetic management for VAD implantation and care in non-cardiac surgery is complex.

Purpose of the Study:

To review current and emerging VADs for pediatric patients.
To discuss anesthetic considerations for VAD implantation in children.
To outline anesthetic strategies for children with VADs undergoing non-cardiac surgery.

Main Methods:

Literature review of VADs in pediatric populations.
Analysis of anesthetic management protocols for VAD implantation.
Review of anesthetic guidelines for patients with VADs undergoing non-cardiac procedures.

Main Results:

Overview of available and investigational VADs suitable for pediatric use.
Key anesthetic techniques and monitoring strategies for VAD implantation.
Perioperative anesthetic management of VAD patients for non-cardiac surgery.

Conclusions:

VADs represent a critical therapeutic option for pediatric heart failure.
Specialized anesthetic care is essential for successful VAD implantation and management.
Optimized anesthetic protocols improve outcomes for VAD patients undergoing non-cardiac surgery.